58 related articles for article (PubMed ID: 31361092)
1. Genetic polymorphisms in very important pharmacogenomic variants in the Zhuang ethnic group of Southwestern China: A cohort study in the Zhuang population.
Li J; Guo C; Yan M; Niu F; Chen P; Li B; Jin T
Medicine (Baltimore); 2018 Apr; 97(17):e0559. PubMed ID: 29703042
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphisms of pharmacogenomic VIP variants in the Lisu population of southwestern China: A cohort study.
Li B; Wang L; Lei L; Zhang M; Niu F; Chen P; Jin T
Medicine (Baltimore); 2018 Sep; 97(38):e12231. PubMed ID: 30235667
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphisms of pharmacogenomic VIP variants in the Uygur population from northwestern China.
Wang L; Aikemu A; Yibulayin A; Du S; Geng T; Wang B; Zhang Y; Jin T; Yang J
BMC Genet; 2015 Jun; 16():66. PubMed ID: 26091847
[TBL] [Abstract][Full Text] [Related]
4. Cell-based Models for Discovery of Pharmacogenomic Markers of Anticancer Agent Toxicity.
Zhang W; Huang RS; Dolan ME
Trends Cancer Res; 2008; 4():1-13. PubMed ID: 21499559
[TBL] [Abstract][Full Text] [Related]
5. Very important pharmacogenetic variants landscape and potential clinical relevance in the Zhuang population from Yunnan province.
Li Y; Chang Y; Yan Y; Ma X; Zhou W; Zhang H; Guo J; Wei J; Jin T
Sci Rep; 2024 Mar; 14(1):7495. PubMed ID: 38553524
[TBL] [Abstract][Full Text] [Related]
6. Genetic Variability of CYP4F2, CYP2D6, CYP2E1, and ACE in the Chinese Yi Population.
Guo J; Zhou W; Ma X; Li Y; Zhang H; Wei J; Du S; Jin T
Biochem Genet; 2024 Jun; ():. PubMed ID: 38850376
[TBL] [Abstract][Full Text] [Related]
7. Analysis of pharmacogenomic variants associated with population differentiation.
Yeon B; Ahn E; Kim KI; Kim IW; Oh JM; Park T
PLoS One; 2015; 10(3):e0119994. PubMed ID: 25807276
[TBL] [Abstract][Full Text] [Related]
8. The landscape of very important pharmacogenes variants and potential clinical relevance in the Chinese Jingpo population: a comparative study with worldwide populations.
Ma X; Li Y; Zang X; Guo J; Zhou W; Han J; Liang J; Wan P; Yang H; Jin T
Cancer Chemother Pharmacol; 2024 May; 93(5):481-496. PubMed ID: 38300251
[TBL] [Abstract][Full Text] [Related]
9. Role of Genetic Polymorphisms in Drug-Metabolizing Enzyme-Mediated Toxicity and Pharmacokinetic Resistance to Anti-Cancer Agents: A Review on the Pharmacogenomics Aspect.
Narendra G; Choudhary S; Raju B; Verma H; Silakari O
Clin Pharmacokinet; 2022 Nov; 61(11):1495-1517. PubMed ID: 36180817
[TBL] [Abstract][Full Text] [Related]
10. Genetic Polymorphism of Drug Metabolic Gene
Zhang T; Li Q; Dong B; Liang X; Jia M; Bai J; Yu J; Fu S
Pharmgenomics Pers Med; 2021; 14():1537-1547. PubMed ID: 34876832
[TBL] [Abstract][Full Text] [Related]
11. Genetic analysis of pharmacogenomic VIP variants in the Wa population from Yunnan Province of China.
Li D; Peng L; Xing S; He C; Jin T
BMC Genom Data; 2021 Nov; 22(1):51. PubMed ID: 34798807
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms of pharmacogenomic VIP variants in the Kyrgyz population from northwest China.
Yunus Z; Liu L; Wang H; Zhang L; Li X; Geng T; Kang L; Jin T; Chen C
Gene; 2013 Oct; 529(1):88-93. PubMed ID: 23954225
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms of pharmacogenomic VIP variants in the lhoba population of southwest China.
He Y; Yang H; Geng T; Feng T; Yuan D; Kang L; Luo M; Jin T
Int J Clin Exp Pathol; 2015; 8(10):13293-303. PubMed ID: 26722533
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphisms study of pharmacogenomic VIP variants in Han ethnic of China's Shaanxi province.
Jin T; Zhao R; Shi X; He N; He X; Ouyang Y; Wang H; Wang B; Kang L; Yuan D
Environ Toxicol Pharmacol; 2016 Sep; 46():27-35. PubMed ID: 27414743
[TBL] [Abstract][Full Text] [Related]
15. A case study of the utility of the HapMap database for pharmacogenomic haplotype analysis in the Taiwanese population.
Lin E; Hwang Y; Tzeng CM
Mol Diagn Ther; 2006; 10(6):367-70. PubMed ID: 17154653
[TBL] [Abstract][Full Text] [Related]
16. Lipid-lowing pharmacogenomics in Chinese patients.
Hu M; Tomlinson B
Expert Rev Cardiovasc Ther; 2013 Aug; 11(8):985-97. PubMed ID: 23952137
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms analysis of pharmacogenomic VIP variants in Bai ethnic group from China.
Chen W; Ding H; Cheng Y; Li Q; Dai R; Yang X; Zhang C
Mol Genet Genomic Med; 2019 Sep; 7(9):e884. PubMed ID: 31361092
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
